CONSORT 2010 statement: extension checklist for reporting within person randomised trials.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
03 2019
Historique:
accepted: 13 05 2017
pubmed: 5 1 2019
medline: 25 2 2020
entrez: 5 1 2019
Statut: ppublish

Résumé

Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.

Identifiants

pubmed: 30609010
doi: 10.1111/bjd.17239
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

534-552

Subventions

Organisme : Medical Research Council
ID : MR/J004871/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2017 The BMJ.

Auteurs

N Pandis (N)

University of Bern, Medical Faculty, School of Dental Medicine, Department of Orthodontics and Dentofacial Orthopedics, Bern, Switzerland.

B Chung (B)

Division of Plastic Surgery, University of British Columbia, Victoria, BC, Canada.

R W Scherer (RW)

Johns Hopkins Bloomberg School of Public Health, Epidemiology Mailroom E6138, Baltimore, MD, USA.

D Elbourne (D)

London School of Hygiene and Tropical Medicine, Department of Medical Statistics, London, UK.

D G Altman (DG)

Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, OX3 7LD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH